Early costs and complications of first-line low-grade glioma treatment using a large national database: Limitations and future perspectives

IntroductionDiffuse Low-grade gliomas (DLGG, WHO Grade II) are a heterogenous group of tumors comprising 13–16% of glial tumors. While maximal safe resection is endorsed as the best approach to DLGG, compared to more conservative interventions like stereotactic biopsy, the added costs and risks have...

Повний опис

Бібліографічні деталі

Автори:	Kyle Tuohy, Djibril M. Ba, Debarati Bhanja, Douglas Leslie, Guodong Liu, Alireza Mansouri
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2023-02-01
Серія:	Frontiers in Surgery
Предмети:	low-grade glioma (WHO grade II) cost resection stereotactic biopsy adverse events—complications MarketScan database
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fsurg.2023.1001741/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!